NEJM - "Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk"

"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk"

"CONCLUSIONS

Among patients at high risk for bleeding who underwent PCI, a polymer-free umirolimus-coated stent was superior to a bare-metal stent with respect to the primary safety and efficacy end points when used with a 1-month course of dual antiplatelet therapy. (Funded by Biosensors Europe; LEADERS FREE ClinicalTrials.gov number,NCT01623180.)" 

http://www.nejm.org/doi/full/10.1056/NEJMoa1503943